David Bauer
Overview
Explore the profile of David Bauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
1907
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pratt E, Shaffer T, Bauer D, Lewis J, Grimm J
J Nucl Med
. 2025 Mar;
PMID: 40081951
Cerenkov (or Cherenkov) luminescence occurs when charged particles exceed the phase velocity of a given medium. Cerenkov as a modality has gained interest for visualization of numerous radionuclides. However, reported...
2.
Ahmed A, Nayak S, Hoteit M, Ameen D, Bauer D, Elshenawy S, et al.
Intern Med J
. 2025 Mar;
55(3):493-502.
PMID: 40055956
Background: Autosomal dominant polycystic kidney disease (ADPKD) is associated with various cardiovascular abnormalities, including spontaneous coronary artery dissection and atrial fibrillation. However, limited data exist to describe the association between...
3.
Chaturvedi S, Weispfenning A, Descamps T, Bellinvia S, Bauer D, Du R, et al.
Clin Transl Oncol
. 2025 Feb;
PMID: 39984775
Purpose: There has been increased difficulty in developing safe and effective treatment using PI3K inhibitors in heme malignancies, despite the role of PI3K/AKT being well defined in this population. This...
4.
Pratt E, Mandleywala K, Bauer D, Bolaender A, Chao G, Castanares M, et al.
Clin Cancer Res
. 2025 Jan;
PMID: 39841860
Purpose: Recent clinical advances with the approval of antibody-drug conjugates targeting Trop-2 such as sacituzumab-govitecan and datopotomab-deruxtecan have garnered tremendous interest for their therapeutic efficacy in numerous tumor types including...
5.
Bauer D, Spanyi S, Neuberg M, Kocka V, Tousek P
Int J Cardiol
. 2025 Jan;
422:132984.
PMID: 39809413
Background And Aims: Myocardial infarction (MI) in multivessel disease (MVD) and chronic total occlusion (CTO) is associated with high mortality. However, all-cause mortality of matched cohort without a CTO is...
6.
Mack K, Bauer D, Carter L, Carrasco S, Atmane M, Viray T, et al.
Nucl Med Biol
. 2024 Nov;
140-141:108976.
PMID: 39615062
Background: Peritoneal metastasis with micrometastatic cell clusters is a common feature of advanced ovarian cancer. Targeted alpha therapy (TAT) is an attractive approach for treating micrometastatic diseases as alpha particles...
7.
Menger M, Tobias A, Bauer D, Bleimehl M, Scheuer C, Menger M, et al.
J Transl Med
. 2024 Sep;
22(1):828.
PMID: 39252093
No abstract available.
8.
Lyashchenko S, Tran T, Happel S, Park H, Bauer D, Jones K, et al.
Nucl Med Biol
. 2024 Aug;
136-137:108943.
PMID: 39094425
Introduction: Zirconium-89 (Zr) is a positron emitter with several advantages over other shorter-lived positron emission tomography (PET) compatible radiometals such as gallium-68 or copper-64. These include practically unlimited availability, extremely...
9.
Bauer D, De Gregorio R, Pratt E, Bell A, Michel A, Lewis J
Eur J Nucl Med Mol Imaging
. 2024 Jun;
51(13):4015-4025.
PMID: 38940841
Purpose: The radionuclide pair cerium-134/lanthanum-134 (Ce/La) was recently proposed as a suitable diagnostic counterpart for the therapeutic alpha-emitter actinium-225 (Ac). The unique properties of Ce offer perspectives for developing innovative...
10.
Niwa M, Bauer D, Anderson M, Kanicki A, Altschuler R, Stewart C, et al.
bioRxiv
. 2024 Jun;
PMID: 38915602
Significance Statement: Our study presents a new method of VsEP quantification using wavelet transform on a single-trial basis. It also describes a novel approach to determine the stimulus threshold of...